- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE invests in ultrasound therapy
No sooner did GE complete one investment than it made another, albeit smaller, one. GE Medical Systems has taken an equity stake in InSightec, a subsidiary of Elbit Medical
No sooner did GE complete one investment than it made another, albeit smaller, one. GE Medical Systems has taken an equity stake in InSightec, a subsidiary of Elbit Medical Imaging. InSightec is developing an MRI-guided, high-intensity, focused ultrasound system as a possible replacement for some surgical procedures. Per the agreement, GEMS will invest $10 million in a combination of cash and equipment for 11.8% of InSightec's shares. GEMS will also convert its previous 5% holdings in InSightec into an additional 5% holding and receive warrants for the purchase of another 5% of InSightec shares for $3 million, exercisable for a period of three years.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.
